Reltecimod
- Generic Name
- Reltecimod
- Drug Type
- Small Molecule
- Chemical Formula
- C46H72N10O15S
- CAS Number
- 1447799-33-8
- Unique Ingredient Identifier
- U00J02UY29
- Background
Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath